Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0280502 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Bärbel Kieninger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, Respiratory Distress Syndrome, Respiratory Insufficiency. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with COVID-19 and severe acute respiratory failure may require veno-venous extracorporeal membrane oxygenation (VV ECMO). Yet, this procedure is resource-intensive and high mortality rates have been reported. Thus, predictors for identifying patients who will benefit from VV ECMO would be helpful.
Methods
This retrospective study included 129 patients with COVID-19 and severe acute respiratory failure, who had received VV ECMO at the University Medical Center Regensburg, Germany, between 1 March 2020 and 31 December 2021. Patient-specific factors and relevant intensive-care parameters at the time of the decision to start VV ECMO were investigated regarding their value as predictors of patient survival. In addition, the intensive-care course of the first 10 days of VV ECMO was compared between survivors and patients who had died in the intensive care unit.
Results
The most important parameters for predicting outcome were patient age and platelet count, which differed significantly between survivors and non-survivors (age: 52.6±8.1 vs. 57.4±10.1 years, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.
- Department of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.
- Department of Cardiac, Thoracic and Cardiovascular Surgery, University Medical Center Regensburg, Regensburg, Germany.
- Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.
- Department of Internal Medicine I, University Medical Center Regensburg, Regensburg, Germany.
- Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany.
ORCID-Profile: Michael Gruber, Martin Kieninger
Zitieren
APA
Kieninger, B., Kilger, M., Foltan, M., Gruber, M., Lunz, D., Dienemann, T., Schmid, S., Graf, B., Wiest, C., Lubnow, M., Müller, T., Salzberger, B., Schneider-Brachert, W., & Kieninger, M. (2023). Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19. PLOS ONE. https://doi.org/10.1371/journal.pone.0280502
Vancouver
Kieninger B, Kilger M, Foltan M, Gruber M, Lunz D, Dienemann T, et al. Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19. PLOS ONE. 2023. doi:10.1371/journal.pone.0280502
BibTeX
@article{Kieninger2023,
author = {Kieninger, Bärbel and Kilger, Magdalena and Foltan, Maik and Gruber, Michael and Lunz, Dirk and Dienemann, Thomas and Schmid, Stephan and Graf, Bernhard and Wiest, Clemens and Lubnow, Matthias and Müller, Thomas and Salzberger, Bernd and Schneider-Brachert, Wulf and Kieninger, Martin},
title = {Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0280502}
}
EUVIMED